Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05985473

Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.

Detailed description

Longitudinal study consisting of multiple visits with multiple examinations over a total duration of approximately 3 years per ANSD participant and 1 year per normal hearing participant. * normal hearing participant : year 1 : Inclusion visit, Phenotyping visit (Audiological tests), Follow-up Visit 1 (Noise Comprehension Tests) * ANSD participant : year 1 : Inclusion visit, Phenotyping visit (Audiological tests), Follow-up Visit 1 (Noise Comprehension Tests) year 2 : Follow-up Visit 2 (Noise Comprehension Tests) year 3 : Follow-up Visit 3 (Noise Comprehension Tests)

Conditions

Interventions

TypeNameDescription
OTHERaudiological measurementsaudiological measurements
OTHERObjective and subjective audiological measurementsObjective and subjective audiological measurements
OTHEREvaluation of the denoising methods REFINEDEvaluation of the denoising methods REFINED

Timeline

Start date
2024-03-06
Primary completion
2026-09-15
Completion
2026-09-15
First posted
2023-08-14
Last updated
2024-03-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05985473. Inclusion in this directory is not an endorsement.